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ZebraﬁshThe incidence of diseases increases rapidly with age, accompanied by progressive deteriorations of physiological
functions in organisms. Aging-associated diseases are sporadic but mostly inevitable complications arising from
senescence. Senescence is often considered the antithesis of early development, but yet there may be factors
andmechanisms in common between these two phenomena over the dynamic process of aging. The association
between early development and late-onset disease with advancing age is thought to come from a consequence
of developmental plasticity, the phenomenon by which one genotype can give rise to a range of physiologically
and/or morphologically adaptive states in response to different environmental or genetic perturbations. On the
one hand, we hypothesized that the future aging process can be predictive based on adaptivity during the early
developmental period. Modulating the thresholds of adaptive plasticity by chemical genetic approaches, we
have been investigating whether any relationship exists between the regulatory mechanisms that function in
early development and in senescence using the zebraﬁsh (Danio rerio), a small freshwater ﬁsh and a useful
model animal for genetic studies. We have successfully conducted experiments to isolate zebraﬁsh mutants
expressing apparently altered senescence phenotypes during embryogenesis (“embryonic senescence”), subse-
quently showing shortened lifespan in adulthoods. We anticipate that previously uncharacterized developmen-
tal genes may mediate the aging process and play a pivotal role in senescence. On the other hand, unexpected
senescence-related genes might also be involved in the early developmental process and regulation. The ease of
manipulation using the zebraﬁsh system allows us to conduct an exhaustive exploration of novel genes and
small molecular compounds that can be linked to the senescence phenotype, and thereby facilitates searching
for the evolutionary and developmental origins of aging in vertebrates. This article is part of a Special Issue en-
titled: Animal Models of Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The mechanisms of aging are currently the focus of extensive
investigations throughout the world. During the aging process, multi-
ple forms of tissue- and organ-speciﬁc damage and pathophysiological
change accumulate, and accordingly a number of chronic diseases
appear with advancing age. Scientists are now hoping for discovery of
the principles governing the ubiquitous process of aging, to ultimately
ﬁnd novel ways to attenuate or delay aging in humans as well as to de-
velop interventions for age-associated diseases. However, understand-
ing the molecular mechanisms of aging in vertebrates is still a major
challenge of modern biology and biomedical science. There are various
animal models to be considered and utilized in aging studies, and
determining the optimal model system(s) remains one of the mostl Models of Disease.
& Aging, The Scripps Research
r, FL 33458, USA. Tel.: +1 561
l rights reserved.important issues. Given certain limitations in each and all the existing
models of human aging, calling for an integrative approach that uses
diverse species in the hope that each would provide a piece of the
puzzle and, together, would help to identify critical elements common
to aging in all organisms. One of the essential limitations is availability
of genetic and genomic information detailed on relevant species. This
provides the rationale for current biomedical investigations into the
mechanisms of aging are conducted concurrently in genetically robust
species like worms, fruit ﬂies, andmice. In fact, small and proliﬁc inver-
tebrates, such as Caenorhabditis elegans (C. elegans) and Drosophila
melanogaster, can provide the strong basis for unbiased genetic screens
that identify and determine the precise functions of novel genes that
regulate aging and lifespan throughout more levels of evolution. This
approach has already led to the successful identiﬁcation of key genes
and pathways evolutionarily conserved in, and associated with, the
aging process. Although evolutionally conserved mechanisms of aging
could play roles in various organisms, manifestations of aging can differ
in different species. For instance, vertebrates from ﬁsh through humans
often die of cancer or stroke, but invertebrates such as worms and in-
sects unlikely die of either. Thus far, only mice have served as a widely
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providing important insights into mammalian aging as an indispens-
able animal model [1]. However, studying only a single genetic model
may be limiting due to diversiﬁed complexity of vertebrate aging
across species. Some mechanisms of aging could be evolutionarily
conserved and publicly common in vertebrates, but there are also
more lineage-speciﬁc or private mechanisms of aging from a compara-
tively biological point of view. Even the common notion that caloric
(or dietary) restriction extends lifespan has not proven to be universally
true, as shown in several cases including humans, someﬁsh species, and
honeybees (Apismellifera) [2–8]. Therefore, a cross-species comparative
biology of aging prospective is necessary to understand and obtain a
more complete picture for fundamental causes of aging in speciation
and biodiversity.
Development is obviously under the precise control of genetic
mechanisms programmed in genome having adaptive plasticity
through epigenome. However, such precise genetic programming
may subsequently be disturbed later on during the aging process
that undergoes many deteriorative challenges against regenerative/
repair responses and restorations where the reactivation of certain
phases of the early developmental program/process contributes
and/or are required. Once we consider aging as an extension of the
biological process of development, the power of zebraﬁsh develop-
ment and genetics becomes a monumental and instructive wealth of
information. Zebraﬁsh can be extensively utilized in searching for evo-
lutionary and developmental origins of aging common in vertebrates.
In fact, some of the genes we identiﬁed by an apparent senescence phe-
notype during embryogenesis (“embryonic senescence”) had already
been associated with cellular senescence and chronological aging in
other organisms, while many have still waited to be linked to the
conventional aging process. Complete loss-of-function of developmen-
tally essential genes induce embryonic (or larval) lethality, whereas it
seems like their partial loss-of-function (i.e., decrease-of-function by
heterozygote or hypomorphic mutations) still remains sufﬁcient to go
through the early developmental process because of its adaptive
plasticity or rather heterozygote advantage. On the other hand, in
some cases such partial loss-of-function of genes compromise normal
homeostasis due to haploinsufﬁciency later in adult life having a num-
ber of environmental or epigenetic challenges which less plasticity
can no longer adjust to compensate. By contrast, any heterozygote-
advantageous genes might gain a certain beneﬁt(s) (much more
ﬁtness) by such partial loss-of-function later in life.
Physiological senescencemay evolutionarily arise from both genetic
and epigenetic drifts as well as from losing adaptive developmental
plasticity in face of stress signals from the external environment that
interacts with functions of multiple genes rather than effects of only
a single gene mutation or defect. We wish to identify a number of
such critical genes promptly in a comprehensive manner by utilizing
the zebraﬁsh model system. Presumably, certain critical portions of
aging phenomena may become readily predictable based on advanced
genetic and genomic approaches in zebraﬁsh, and a systems biology
approach will allow us to simulate the aging process by modeling po-
tential stochastic values including epistatic and epigenetic effects.
2. Zebraﬁsh as a new vertebrate model of aging
Zebraﬁsh has emerged as a highly promising model for studies of
vertebrate aging [9–14]. Combining their optical transparency at em-
bryonic and larval stages (in some cases, even in adults throughout
their lives; [15]), the small size and high fecundity of zebraﬁsh have
made them a favorite vertebrate of developmental biologists. This
has resulted in detailed characterization of the zebraﬁsh genome,
the development of multiple mutant and transgenic phenotypes,
and the emergence of various molecular genetic techniques
(e.g., most recent targeted-gene knockout using nucleases as well as
authentic knockdown using morpholino antisense oligos) allowingfor investigation of the intrinsic mechanisms underlying normal
physiological and pathological events in this organism [16–20]. Con-
sequently, of the vertebrates studied to-date, zebraﬁsh offers the
most cost-effective opportunity for high-throughput screens using
robotic systems for evaluating mutants, identifying genes, and testing
chemicals in vertebrate organisms [21–23].
Zebraﬁsh live for approximately 3 years on average (over 5 years
maximally) in laboratory conditions and show gradual senescence
that is similar in many aspects to humans [9,11]. With age, zebraﬁsh
often display spinal curvature that is possibly related to muscle abnor-
malities [11]. In aging zebraﬁsh, we detected senescence-associated
β-galactosidase (SA-β-gal) activity in skin (Fig. 1) [9,14,24]. As
zebraﬁsh age, they show increased accrual of lipofuscin (“aging
pigment”) in the liver and accumulation of oxidized proteins in muscle
[9,24], similar to that reported in mice and humans [25–27]. Aged
zebraﬁsh also often develop lipofuscin accumulation and drusen-like
lesions in retinal pigment epithelium (RPE), which is similar to that
seen in age-related macular degeneration (AMD) in humans. More-
over, almost all zebraﬁsh develop cataracts by 4 years of age
(unpublished observation), when the majority of the oldest ﬁsh show
retinal atrophy [24].
Our studies have further revealed several age-related degenerative
changes and increases in a variety of pathological lesions in aging
zebraﬁsh, as well as an age-dependent decline in both their reproduc-
tive and regenerative capacity [9,14,24]. In adult zebraﬁsh, ﬁn regener-
ation is a highly orchestrated processes involving wound healing,
establishment of the wound epithelium, recruitment of the blastema
from mesenchymal cells underlying the wound epithelium, and differ-
entiation and outgrowth of the regenerated cells [28]. Importantly,
such regenerative ability declines with age, leading to impaired
morphology and distorted ﬁn shape [14], which may become a valu-
able hallmark of aging in this animal model.
There have also been observed age-associated alterations in circadi-
an rhythmicity, sleep and cognitive function in zebraﬁsh [12–14,29].
Taken together, these observations suggest that zebraﬁsh are the
great model to investigate the mechanisms underlying gradual senes-
cence in vertebrates, and could serve as a promising model of human
aging [9,24].
3. High-throughput mutant screening for senescence-aging
in vertebrates
In addition to studying the function of speciﬁc genes that have
already been linked to the aging process, it is critically important to
conduct unbiased mutant screens for aging phenotypes in vertebrates,
in search of additional genes that affect late-onset diseases or
age-related dysfunctions. The mechanisms connecting the organismal
aging process with multiple chronic age-associated human diseases
(‘geriatric diseases’) remain a complex enigma, and scientists some-
times face conﬂicting arguments about ‘aging phenotypes’ versus
‘diseases’. Both intrinsic gene-gene interactions (‘epistasis’) and envi-
ronmental factors, as well as gene–environment interactions [30,31],
affect the aging process and disease progression. It is however poorly
understood which of the complex genetic elements evolutionarily af-
fect lifespan, how they are correlated with disease susceptibility, and
how environmental and epigenetic modulations are responsible for
the developmental origins of aging and disease in vertebrates. There
may be remarkably complex interactions between unexpected, as of
yet unidentiﬁed and/or even unrelated genes, requiring unbiased com-
prehensive methods of detection and systems biology approaches to
their identiﬁcations. In most vertebrates, unbiased screens for aging
mutants are technically difﬁcult and have therefore not yet been
done, even in mice. On the other hand, speciﬁc phenotype-based and
unbiased forward genetic screens in early development for multiple
biological and biomedical purposes have already been successfully
carried out in zebraﬁsh, and can be readily adapted to current aging
Fig. 1. Increased senescence-associated β-gal (SA-β-gal) activity in the trunk skin of the adult zebraﬁsh with age [24]. (A, B) Lateral imaging of 5-month (0.42 y) old (A) and
57-month (4.75 y) old (B) whole adult zebraﬁsh stained for SA-β-gal activity. (Scale bar: 0.5 cm.) (C) Quantitative analysis of trunk SA-β-gal staining in ﬁsh of various ages showing
a near-linear increase in SA-β-gal activity with age. In (C), the numbers of ﬁsh at each time point (years) were: 0.42 y (n = 16); 0.58 y (n = 14); 0.75 y (n = 13); 1 y (n = 14);
1.83 y (n = 15); 2.5 y (n = 6); 2.6 y (n = 8); 3.58 y (n = 14); 3.66 y (n = 12); 3.92 y (n = 22); 4.75 y (n = 5). R2 = 0.3027. y; year(s) of age.
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can be applied to this model system, particularly in embryos and/or
larvae during the developmental process.
The features that distinguish the zebraﬁsh as a high-throughput ame-
nable organism for high-content or large-scale screens include their
small body size, transparent embryogenesis, and high reproductive
rate, allowing the simultaneous evaluation of many siblings throughout
their lives under controlled conditions, with and without certain envi-
ronmental and pharmacological challenges. Moreover, the existence of
various zebraﬁsh mutants and traceable transgenic lines showing
particular phenotypes already, including retroviral insertional mutantFig. 2. Gene mutations resulting in altered (half) dosages of particular gene functions and lead
slope of the solid black line illustrates the age-dependent regression of accuracy in gene functio
structural cellular damage following intrinsic and extrinsic (environmental) stochastic events, d
shows the age-dependent decline of accuracy in gene function in a heterozygous (Het) mutant
gene function at birth leading to a shorter (‘heterozygote disadvantage’) or longer (‘heterozygot
at which certain ‘Aging Biomarkers’ can be documented, i.e., aging biomarker thresholds; A and
haploinsufﬁciency), shifted lines to the left by arrows illustrate themore rapid decline of accura
or gamma-radiation that we used in our studies) in wild-type or heterozygous mutant organism
middle age (Mid-Age). In the heterozygous mutant, this Aging Biomarker-Amanifests spontan
above the 50% level of gene function, thus predicting an accelerated aging phenotype. In contra
heterozygous mutants at a relatively earlier period of late adult life. Thus, neither organism wo
ganisms, exposure to stress during development or later in life can change the dynamics of ge
cells. As a result, after stress, both Aging Biomarkers manifest earlier and the Aging Biomarker-
ganism. In homozygous (Mu; Homo) mutant organism, either Aging Biomarker-A or -B can be d
early lethal (on X-axis). Thus, the search for gene mutations that lead to accelerated aging ph
heterozygous mutants with or without the use of environmental stress factors. Note that while
aging in zebraﬁsh mutants with altered spns1/nrs and terf2 genes, it does not reﬂect themore c
dicted by the “antagonistic pleiotropy” theory of aging [30,91]. Moreover, the concerted effect o
all aging process to exhibit non-linear dynamics, with stochastic environmental factors prov
epigenetic drifts). In the lower schematic (in mutants of Type II Genes with heterozygote adva
ously in early development without stress insult (on Y-axis), since its threshold lies above the
Biomarker-B is characteristic of old age in thewild-type animals andmanifests in heterozygous
would not show this biomarker spontaneously during early development. Exposure to stress d
with age, probably due to resistance to structural and functional damage to cells. As a result, e
Aging Biomarker-B can only be detected during Mid-Age of the heterozygous mutant beyond
-B could be “negatively” detected during early development (i.e., decreased SA-β-gal activity)
withmutations in Type I Genes and increased SA-β-gal activity, thenormal (Wt) allele (Normal
Hetero) allele (Hetero Gene I) could be rather more deleterious and induce accelerated aging a
tants are categorized as type I). On the other hand, in suppressor mutants with mutations in T
more deleterious later in life in terms of senescence but the heterozygousmutant allele (Hetero
in this regard (The 3mutants are categorized as type II). These heterozygousmutants are anticip
null mutants have no ﬁtness with lethality.collections [32], provides a valuable rich resource for the identiﬁcation
of both physiological and pathological aging characteristics.
4. Utility of a biomarker of “embryonic senescence” to predict the
chronological aging process
Humans develop and age very gradually, when compared with
most of the animals used as biomedical research model systems
(some notable exceptions include a certain species of rockﬁsh
which can live for over 200 years). This may be a critical limitation
of the current study and approach, since some of the aging processesing to altered senescence outcomes through the aging process. (A) In the schematic, the
n in a wild-type (Wt) organism due to in part to “programmed” senescence, accumulated
esynchronization ofmolecular mechanisms, and so on. The slope of the gray or green line
organism identiﬁed in our screening i.e., the mutants with a presumed 50% loss of original
e advantage’) lifespan (on X-axis). Dotted horizontal lines depict the level of gene function
B. (B) In upper schematic (in mutants of Type I Genes with heterozygote disadvantage or
cy in the function of the same gene following early exposure to stress (e.g., oxidative stress
s. According to this model, in wild-type organisms, Aging Biomarker-A manifests around
eously even in early development without stress insult (on Y-axis), since its threshold lies
st, Aging Biomarker-B is characteristic of old age in a wild-type organism andmanifests in
uld show this biomarker spontaneously during early development. However, in both or-
ne function with age, presumably through additional structural and functional damage to
B can now be detected earlier in life of the heterozygous mutant but not the wild-type or-
etected during early development (i.e., increased SA-β-gal activity) and themutations are
enotypes can be conducted during early development of homozygous mutants as well as
this highly-simpliﬁed schematic illustrates changes that helped us to predict accelerated
omplex relationships between the dynamics of gene functions and age that would be pre-
f numerous genes functioning in parallel throughout lifewould predictably cause the over-
iding further modiﬁcations of age-dependent processes under real-life conditions (e.g.,
ntage’), for the heterozygous mutant, the Aging Biomarker-Amay still manifest spontane-
50% level of gene function, thus predicting an delayed aging phenotype. In contrast, Aging
mutant during relatively late adulthood beyond the age ofwild type. Thus, such organisms
uring development or even later in life can maintain the robust dynamics of gene function
ven after stress, although Aging Biomarker-A may still manifest relatively earlier but the
the wild-type age. In the homozygous mutants, certain however Aging Biomarker-A or
and these mutations are also still early lethal (on X-axis). In the case of enhancer mutants
Gene I) can bemore beneﬁcial to be against senescencebut theheterozygousmutant (Mut:
nd subsequently a shorter lifespan as seen in the spns1/nrs and terf2mutants (The 11mu-
ype II Genes and decreased SA-β-gal activity, the normal allele (Normal Gene II) could be
Gene II) may bemore beneﬁcial to be against senescence having ‘heterozygote advantage’
ated to show slowor delayed aging and a longer lifespan. However, the homozygous (Mu)
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become apparent, and simply short-span models might not be
adequate to elucidate the essential determining factors of the gradual
nature and mechanisms of aging. On the other hand, the lengthy
lifespan of experimental animals represents a practical obstacle for un-
dertaking either cross-sectional or longitudinal aging research, particu-
larly in comprehensive genetic studies and high-throughput mutant
screens.
One of the most promising approaches to confronting this dilemma
is to assess rather young animals (even embryos and larvae) for reli-
able and easily measurable biomarkers of senescence that “predict”
an actual (both chronological and biological) aging phenotype(s)
appeared later in life. In genotypes susceptible to accelerated aging
(caused by ‘Heterozygote Disadvantage’) or even delayed aging
(caused by ‘Heterozygote Advantage’), such biomarkers might mani-
fest in young animals with certain gene mutations (or alleles), either
spontaneously or following stress (Fig. 2A). Even if such mutations
are lethal in homozygous zebraﬁsh, most heterozygous animals devel-
op normally and survive into adulthood. Under normal conditions, the
heterozygous embryos, larvae, or young (adult) ﬁshmight not immedi-
ately reveal signiﬁcant vulnerable changes in biomarkers of aging, due
to the presence of ‘plasticity’ like partial redundant compensatory
mechanisms and/or adaptive responses and upregulations (e.g., hyperA
Bactivation) mediated by the remaining intact functional allele. Howev-
er as conﬁrmed by our recent study [24], several homozygous mutant
(complete loss-of-function) conditions as well as exposures of the
corresponding heterozygote carriers to speciﬁc stress challenges can
help to amplify the response in animals showing dominant premature
senescence (“embryonic senescence”) phenotypes even in early devel-
opment (in case of senescence “enhancer mutants” of Type I genes by
haploinsufﬁciency; Fig. 2B). This applies to cases where genemutations
lead to an augmented response to stress (in Type I genes) or conversely
a resistance to it (in Type II genes). Thus, a mutant phenotype in homo-
zygosity as well as a speciﬁc stress challenge (instead of an actual aging
challenge) in heterozygosity during early development could mimic
the actual aging process and help to predict the genotypes that might
be susceptible or resistant to homeostatic deteriorations that occur
during aging. By using a chemical sensitizer (e.g., hydrogen peroxide),
we could indeed identify mutants with an altered response to oxidative
stress; that is we expected the chemical sensitizer to induce “heterozy-
gote advantage or disadvantage” impacts in many of the potential
target genes. We then denoted this chemical genetic methodology
‘CASH’ (Chemically Assisted Screening in Heterozygotes) [24].
One obvious biomarker of aging to use in unbiased screens is
SA-β-gal, an indicator of cellular senescence in vitro as well as of or-
ganismal aging in vertebrates [33–38]. In fact, we detected SA-β-gal
~500 mutant genomes induced by
retrovirus insertional mutagenesis and ENU chemical
mutagenesis
Stress-mediated SA- -gal induction as a hallmark
of senescence in embryos or larvae within 5 days
With oxidative stress
in heterozygote 
Without oxidative stress
in homozygote 
~15 candidate mutations have been identified
Fig. 3. A scheme of “embryonic/larval senescence” mutant screening in zebraﬁsh.
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muscle of aging zebraﬁsh [9,14,24], similar to that demonstrated in
humans with age [33]. We employed this marker in a series of screens
for embryonic senescence phenotypes using 306 retrovirus-mediated
insertional zebraﬁsh mutant lines and more others by N-ethyl-N-
nitrosourea (ENU) chemical mutagenesis (approximately total ~500
mutant genomes) [24,32] (Fig. 3). Since all of the 306 insertional
mutations screened were ultimately homozygous lethal, we needed
to explore the effects of missing just one copy of the genes
(‘haploinsufﬁciency’) in heterozygous adult ﬁsh with age. However,
instead of characterizing their aging phenotypes throughout their
lifespan, we ﬁrst examined which of these mutants showed increased
SA-β-gal activity during embryonic development within 5 days post
fertilization (dpf), either spontaneously in homozygote or following
oxidative stress in heterozygote [24]. All the mutants showing the al-
tered SA-β-gal activities are currently available at the Zebraﬁsh Inter-
national Resource Center (ZIRC): bhttp://zebraﬁsh.org/zirc/ﬁsh/line
All.php?t=Anything&c=aging&searchMenuQuick=Go>.
It is possible to hypothetically model our mutant screening of de-
velopmentally essential (potentially ‘beneﬁcial’ versus ‘deleterious’)
genes for embryonic senescence considering the actual aging process
(Fig. 2). In enhancer mutants (harboring mutations in Type I Genes)
with increased SA-β-gal activity, the normal allele can be more
‘beneﬁcial’ to be against senescence, whereas the heterozygous
mutant allele could be rather more ‘deleterious’ in this sense showing
accelerated aging and a subsequently shorter lifespan (as evident in
the spns1/nrs and terf2 mutants out of the total 11 mutants catego-
rized in this type A group; discussed further below). On the other
hand, in suppressor mutants (having mutations in Type II Genes)
with decreased SA-β-gal activity, the normal allele could be relatively
more ‘deleterious’ in senescence but the heterozygous mutant allele
may be more ‘beneﬁcial’ against senescence, having ‘heterozygote ad-
vantage’ of ﬁtness (The 3 mutants are categorized as this Type II, as
discussed below). These heterozygous mutants are anticipated to
show slow or delayed aging and thus a longer lifespan.
From the pool of 306 mutants, we identiﬁed 11 mutant genotypes
that showed increased higher embryonic SA-β-gal activity and were
designated as enhancer mutants (Fig. 4), and raised two of these
lines to maturity. One of these mutants was found to be null for a
homologue of Drosophila spinster (spinster homolog 1/not really
started; spns1/nrs), a gene known to regulate lifespan in ﬂies [39],
whereas the other harbors a mutation in a homologue of the human
telomeric repeat binding factor 2 (terf2) gene, which plays roles in telo-
mere protection and telomere-length regulation [40,41]. In fact, adult
ﬁsh that are heterozygous for these mutations show the premature
expression of aging biomarkers and the accelerated onset of aging
phenotypes including increased SA-β-gal activity, an enhanced accu-
mulation of lipofuscin granules and shorter lifespan, compared with
their control siblings. Our current strategy of mutant screening for a
senescence-associated biomarker in zebraﬁsh embryos may thus
prove to be a useful new approach for the genetic dissection of verte-
brate stress response and senescence mechanisms. Importantly, these
two genes have been already linked to the organismal aging process
(spinster in Drosophila) and cellular senescence (terf2 in mice and
human cells), respectively [39,42,43]. Thus, this approach allows us
to establish the ‘proof-of-principle’ that prominent increases in em-
bryonic SA-β-gal activity correlate with accelerated adult aging phe-
notypes by haploinsufﬁciency in the mutants. The remaining other 9
genes linked to increased SA-β-gal activity during embryogenesis
await more full characterizations at mature stages (Fig. 4), but remain
signiﬁcant interests for their potential involvement and roles in aging.
Each gene linked to increased embryonic SA-β-gal activity is listed in
Table 1.
Another intriguing gene identiﬁed by increased embryonic SA-β-gal
is smoothened (smo) that is originally well known to function promi-
nently in different developmental contexts, as shown from agingstudies that have examined the Hedgehog pathway [44,45]. Smo is a
G protein-coupled receptor for Hedgehog signaling [46]. The essential
role of Smo in brain development is well established, and the function-
al presence in adult brain suggests its importance beyond the early
developmental stages [47]. Indeed, recent evidence suggests that
Hedgehog, acting through Smo, plays a critical role in the expansion
and establishment of postnatal hippocampal neural progenitors [48].
Moreover, it has been revealed that there is a potential involvement
of Hedgehog signaling in maintaining adult hair follicle stem cells
[45], and a certain functional role of the Hedgehog pathway in the ret-
inal aging process has also been highly anticipated [44]. Therefore, fur-
ther characterizations of zebraﬁsh smo mutants promise to provide
crucial information regarding the new function of this gene in aging
and senescence beyond early development.
The fact that these interesting mutants were selected based on
increased SA-β-gal activity during early development, while no ap-
parent abnormalities were found in heterozygous individuals early
on, although at least the two of them show the accelerated aging
phenotypes later in adult life, underscores the utility of such an
approach for identifying early predictors of actual aging phenomena.
This suggests that ‘haploinsufﬁciency’ in some genes might not be
detrimental to a developing embryo probably due to adaptive devel-
opmental plasticity, but would facilitate alterations in molecular
mechanisms and physiological functions characteristic of aging. If
biomarkers of such alterations could be documented at an early age,
they could help to predict subsequent aging phenotypes later in life.
Furthermore, our mutant screen also revealed three genotypes des-
ignated as suppressor mutants with a relative decrease of SA-β-gal ac-
tivity during early development (Fig. 5). Each gene linked to
decreased embryonic SA-β-gal activity is also listed in Table 1. These
genes are also of interest for their potential involvement in aging of
physiological functions, particularly with regard to the possible exis-
tences of long-lived zebraﬁsh mutant animals. The 3 mutants whose
SA-β-gal levels were signiﬁcantly lower harbored the mutations in eu-
karyotic translation initiation factor 3, subunit D (eif3d), ribosomal protein
L11 (rpl11), and small nuclear ribonucleoprotein D1 polypeptide (snrpd1).
These genes are involved in protein synthesis, ribosomal functions, and
RNA–protein interactions, respectively. The presence of lower SA-β-gal
levels in these mutant embryos (‘suppressor mutants by loss-of-
function’) is intriguing and makes them attractive for further exploring
the possibility of slow or delayed aging regulated by any heterozygote
Table 1
Embryonic/larval senescence mutants.
Embryonic SA-β-gal
activity
Gene GenBank accession
no.
Enhancer by
loss-of-function
Spinster homolog 1 (spns1) NM_153663
Telomeric repeat binding factor a
(terfa; terf2)
NM_173243
Clathrin interactor 1a (clint1a) NM_001003412
ATPase, H+ transporting, lysosomal,
V0 subunit c, a (atp6v0ca)
NM_001105136
ATPase, H+ transporting, lysosomal,
V1 subunit H (atp6v1h)
NM_173270
Polymerase (RNA) II (DNA directed)
polypeptide D (polr2d)
NM_001002317
Polymerase (RNA) II (DNA directed)
polypeptide G-like (polr2gl)
NM_199669
Smoothened homolog (smo) NM_131027
CCR4-NOT transcription complex,
subunit 1 (cnot1)
NM_001079951
Structural maintenance of
chromosomes 1A, like (smc1al)
NM_212810
Denticleless homolog (dtl) NM_173241
Suppressor by
loss-of-function
Eukaryotic translation initiation
factor 3, subunit D (eif3d)
NM_200016
Ribosomal protein L11 (rpl11) NM_001002139
Small nuclear ribonucleoprotein
D1 polypeptide (snrpd1)
NM_173252
Fig. 5. Retrovirus-insertional mutants showing low (decreased) SA-β-gal activity [24].
There were the three different mutants (shown by duplications) with low SA-β-gal
intensity, hi3820B (60S ribosomal protein L11 gene) (n = 12; 5 dpf), hi2230 (eukaryotic
translation initiation factor 3, subunit 7 gene) (n = 15; 4 dpf), and hi601 (small nuclear
ribonucleoprotein D1 gene) (n = 14; 3.5 dpf). Representative SA-β-gal stained homo-
zygous embryos (two individuals from each of these three mutant groups) are shown.
Fig. 4. Retrovirus-insertional mutants showing high (increased) SA-β-gal activity [24].
The 11 homozygous 3.5 days post-fertilization (dpf) retrovirus-insertional mutants
stained with high SA-β-gal are shown in comparison with a wild-type control (with
1-phenyl-2-thiourea; PTU). All of the original information we obtained regarding
these mutants is summarized in the table of our previous publication [24].
1367T. Sasaki, S. Kishi / Biochimica et Biophysica Acta 1832 (2013) 1362–1370advantage. Identiﬁcation of longevity assurance genes, which can ex-
tend lifespan, should be elucidated to better establish the existence of
aging-related genes in the zebraﬁsh model system. Therefore, we cur-
rently anticipate being able to identify a real suppressor-type agingmu-
tant, which displays enhanced stress resistance in advanced age and,
perhaps, a longer healthy lifespan (“healthspan”). Alternatively, it
might also be possible to isolate a “revertant” from the background of
an accelerated aging mutant, which would restore the original normal
phenotype with rejuvenation by means of any suppressor mutation
(i.e., a reversal of the accelerated aging phenotype).
Our studies have demonstrated to date that the certain environ-
mental challenges that can accelerate aging in adult zebraﬁsh,
e.g., gamma-irradiation or oxidative stress, can be effective in revealing
biomarkers of aging during early development. If the coupling of stress
responses in zebraﬁsh embryos and/or larvae with aging mechanisms
in adult ﬁsh works parallel fashion, as has been demonstrated in
other invertebrate animal systems and suggested by our results
discussed here, this approach will be a useful and powerful tool in
the search for aging-related genes more comprehensively in verte-
brates. Such speedy identiﬁcation of genes relevant to vertebrate
aging using embryos and/or larvae would partially circumvent the
need for time-consuming and lengthy lifespan analyses in any available
zebraﬁsh mutants or even natural variants.
5. Developmental origins of aging and disease
Genetic information determines the architecture of individual or-
ganisms during development and programs the mechanisms thatmaintain adequate functions during adult life [49]. There is also sub-
stantial evidence which shows that constraints in early life environ-
ment are an important determinant of the risk of geriatric diseases
including cancer and metabolic disease [50,51]. One hypothesis is
that the increased susceptibility to such diseases has a common origin
with the developmental changes induced in the developing tissues
and organs under initially exposed particular environmental condi-
tions, as originally proposed by Barker [52]. The developmental and
environmental impacts include nutritional status and altered epige-
netic regulation of speciﬁc genes having each genetic background.
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dependent upon the nature of the environmental challenges as well
as on the interaction of the original genetic susceptibility with the al-
tered epigenome throughout the life course [53]. However, age-
related physiological changes and pathologies may also originally
derive from the drifting actions of developmental programs [54].
Age-associated epigenetic drifts in an intrinsic developmental pro-
gram that tends toward imbalance with advancing age can be a
cause of the progressive deteriorative changes in physiological func-
tions and homeostasis, leading to various diseases [55,56].
With aging, regenerative ability also declines and degenerative
potential increases in zebraﬁsh as we discussed above [14]. The
loss/decrease of plasticity and/or onset of self-renewal defects in
stem cells may be responsible for reduced regenerative capability
and inefﬁcient tissue restoration accompanied by aging. On the
other hand, inadequate elasticity in aging may cause inappropriate
regeneration leading to cancer or degeneration by compromising
homeostatic integrity and plasticity. The fundamental aging process
is not a disease itself, whereas aging obviously increases vulnerability
to many diseases including cancer. In essence, therefore, aging may
be considered to be one of the most prominent pathogens and
carcinogens. Cancer incidences exponentially increase with age in
most vertebrate species as shown in zebraﬁsh as well as humans
[57–59]. This age-associated increase of cancer incidence is presum-
ably due to inappropriate developmental drift in aging stem cells or
aged somatic cells which are voluntarily trying to reset a program
having certain troubles. Most of proto-oncogenes function properly
in normal development and growth. Developmentally crucial genes
such as oct-3/4 and sox2 and the proto-oncogene c-myc among others
can reprogram differentiated somatic cells to stem cells beyond plas-
ticity [60–62]. However, such artiﬁcially (or even naturally) induced/
reversed stemness is insufﬁciently robust and often suffer from
inevitable carcinogenesis owing to the conﬂicting relationship be-
tween reversing power and forwarding entropy in senescence [63].
Inappropriate fading or unexpectedly excessive actions of develop-
mental functions in the adult stages is conceivably caused by less
molecular ﬁdelity with increasing entropy [64,65]. The reason why
adaptive plasticity is restricted to a particular period of early life is
possibly that there is a difﬁculty in reversing the entire developmen-
tal processes of adult organisms in vivo [50]. Thus, it might be due to
the unaffordable energy cost of assuring reproductive success and
ﬁdelity in reconstructing the prior established characteristics of
aging organisms.
Segmental progeroid syndromes including Hutchinson–Gilford
progeria syndrome (HGPS) (simply referred to as “progeria”) are
often accompanied by developmental and growth retardation, but
very little is known about the developmental process of such accelerat-
ed aging disorders. We have demonstrated the impaired early develop-
mental processes of the mesenchymal lineage in zebraﬁsh embryos
harboring the disturbed lamin A expression [66], and other lines of
evidence also support the notion that developmental signaling path-
ways are presumably involved in the lamin A-associated aging mecha-
nisms as well [67]. Because embryonic stem cells appear to express
lamin A/C upon differentiation [68], and lamin A-associated stem cell
dysfunction has been linked to disruption of theWnt and Notch signal-
ing pathways [67,69–71], which are essential for early vertebrate
development, our observations of embryonic senescence or apoptosis
in the lamin A gene (LMNA)-disturbed zebraﬁsh might be consistent
with a dysregulation of somatic stem cells leading to organismal
premature aging. In particular, it is plausible that the less adaptive
plasticity and insufﬁcient self-renewal ability in mesenchymal stem
cells may be responsible for the speciﬁcity of accelerated tissue degen-
eration, as most affected tissues in progeria are of mesenchymal origin
[70]. Embryonic senescence and further unforeseen developmental ab-
normalities may also be occurring in human (or mice) progeria given
that severe neonatal lethality has been reported [72–74]. Thus, agingresearch should therefore extend to the study of early developmental
process at least within the context of reproduction and regeneration.
It is reasonable to assume that the developmental theory of aging
approach eventually leads to the identiﬁcation of genes and pathways
which are relevant for development alone, for aging alone, and for
both development and aging [75]. As a fundamental ﬁrst task, the
pathways that have already been implicated in aging and longevity
can be more extensively investigated in early development, as we
have been working on the several gene products including lamin A,
ataxia telangiectasia mutated (ATM), and telomerase [66,76,77].
6. Juvenile protective and rejuvenating factors against aging
Little attention has been devoted to determining ‘physiological’
factors characteristic of early life that could be protective to adult
health and contribute to healthy aging. This is presumably because
‘premature aging’ during early life has often been considered
pathological rather physiological as a canonical context. Conceivably,
however, our identiﬁed genes of senescence enhancers by loss-of-
function might encode juvenile protective and/or rejuvenating factors
that could normally act to delay aging and that when mutated can
cause premature aging.
The morphogenic signals mediated by Hedgehog and Wnt are
essential to direct pattern formation during embryogenesis and both
the signal activities can remain through adulthood. Consistently, it
has been reported that both Hedgehog and Wnt pathways function in
aging [44,78–80]. In addition, critical roles of Hedgehog and Wnt
signals have been implicated in metabolic regulatory events including
insulin sensitivity and fat formation [81,82]. In lines with these, as we
described, our embryonic senescence mutant screens have identiﬁed
the Hedgehog signal transducer, Smo, as a driver of SA-β-gal activity
by the loss of its function [24]. Moreover, haploinsufﬁcient accelerated
aging phenotypes in retinal photoreceptors via the heterozygous
hedgehog genotype have been reported in zebraﬁsh [44]. Thus, Hedge-
hog signaling may function as an aging antagonist or rejuvenating
factor [83,84]. The outcome of several plausible candidate mutants in
our mutant screening, like smo mutant ﬁsh, in addition to spns1/nrs
and terf2 mutant ﬁsh, has already provided a proof-of-concept for our
original approach to assess the rejuvenating connection between de-
velopmental and senescence signaling pathways through the common
genes during embryogenesis in zebraﬁsh.
The secreted factor Klotho, which acts as a proﬁcient suppressor of
aging, may also be classiﬁed as a rejuvenating factor. Klotho-deﬁcient
mice manifest a syndrome resembling accelerated human aging with
multiple deteriorative features [85], whereas Klotho-overexpressed
mice extend lifespan displaying anti-aging properties [86]. In the
Klotho-deﬁcient animals, increased Wnt signaling activity becomes
evident, and in fact Klotho functions as a secreted Wnt antagonist.
Klotho binds to various Wnt family members, and Klotho deﬁciency-
induced accelerated aging is due, at least in part, to constitutive Wnt
signaling. Hence, an unexpected deleterious role of Wnt in aging has
been revealed in a Klotho-deﬁcient mouse model system, while other
lines of evidence contradictorily support a beneﬁcial effect(s) of a
Wnt signaling against on aging as it can ameliorate multiple age-
associated symptoms [87]. A tissue-dependent imbalanced regulation
between Klotho and Wnt may be caused by developmental drift in
aging stem cells and become a reason of reduced plasticity in tissues
and organs with age.
Importantly also, essential involvements of Notch and Wnt signal-
ing pathways in the deterioration of stem cells from progeria patients
and model mice have been described, respectively [67,69–71]. In
human progeria, Notch signaling is upregulated in mesenchymal
stem cells, leading to activation of the downstream target genes and
to increased osteogenesis and decreased adipogenesis by perturbing
cellular differentiation. Furthermore, in progeria model mice, the tran-
scriptionally active form of β-catenin, which is the well-characterized
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Moreover, given the recent ﬁndings that Wnt signaling and the
telomerase catalytic subunit (telomerase reverse transcriptase; TERT)
can potentially make a positive regulatory loop: the Wnt pathway
component β-catenin can positively regulate the expression of TERT
while TERT can positively regulate the expression of Wnt/β-catenin
target genes [88,89], it is now reasonable to propose that the new direct
link between theses mechanistic regulations have a crucial impact on
balancing regeneration/rejuvenation and cancer during the aging pro-
cess beyond embryogenesis [90].
Taken together, the cumulative lines of evidence support the
notion that developmental signaling pathways and their possible
drifting actionsmay be involved in the aging and rejuvenationmech-
anisms [54], where we recognize that the zebraﬁsh model system
can enormously contribute to the identiﬁcation of juvenile pro-
tective and rejuvenating factors against aging and the study of mo-
lecular mechanisms to reverse the aging process that are common
amongst vertebrates.
7. Conclusions
Our ﬁndings from the recent studies suggest that ‘embryonic senes-
cence’ in zebraﬁsh can be connected to the process of actual aging,
which manifests at both the cellular and organismal levels. These
include morphological and histological changes in multiple tissues,
reduced regeneration and damage to macromolecules (DNA, proteins,
and lipids), lipofuscin accumulation possibly resulting in reduced intra-
cellular trafﬁcking, cognitive decline, circadian dysregulation, and sleep
alterations among others. These hallmarks of aging, also typical of other
vertebrates, have been used in our longitudinal study of aging pheno-
types among the zebraﬁsh mutants that were identiﬁed based on
early-life evaluations. This and other examples indicate that zebraﬁsh
can become an ideal system to develop alternative vertebrate models
in order to address the many biological questions regarding the rela-
tionship between vertebrate development and aging in a more amena-
ble throughput setting.
Aging has been thought of as a stochastically ‘deteriorative/
destructive’ process, whereas development is a ﬁnely ‘programmed/
constructive’ process. However, the genetic robustness of aging may
already be deﬁned during early developmental stages. For instance,
a certain gene mutation might lead to accelerated decline in gene
function that would normally occur only at old age, and this process
could be facilitated by challenging of multiple stressors which can
mimic various environmental effects. In such cases, robust biomarkers
of aging could be potentially revealed at a much earlier age. As we
have shown in the previous study, this issue can be fruitfully explored
using unbiased genetic mutant screens for senescence-associated bio-
markers during early developmental stages [24]. Overall, we propose
that the complexity of aging in higher organisms, involving the inter-
action of multiple genes and signaling pathways, warrants a compre-
hensive search for the evolutionary developmental origins as early
predictors of altered aging phenotypes later in life, where we might
be able to reverse the process. The zebraﬁsh animal model, with its
well-established genetics and advanced high-throughput technolo-
gies, offers an unparalleled opportunity to identify aging-related genes,
and to easily analyze their function throughout life. The highly con-
served mechanisms of aging on the cellular, tissue and organismal
levels can and should be addressed using zebraﬁsh as the most af-
fordable genetic model in vertebrates, comparable to C. elegans and
Drosophila in invertebrate.
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